Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹800 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,513.6 Cr -1% -4.9% 35.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr 0.6% -2.8% 6.2% Stock Analytics
DIVIS LABORATORIES ₹176,570.0 Cr 0.4% 0.1% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,670.0 Cr 3.4% 4.3% 42% Stock Analytics
CIPLA ₹111,725.0 Cr -1.3% 7% -7.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,424.0 Cr -0.2% 0.4% -1.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1%

-4.9%

35.3%

SENSEX

-0.7%

-2.9%

-8.9%


You may also like the below Video Courses